5 drugs reach their earliest generic-entry date in 2026

Nov 2026 · 1

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Naropin · 2 strengths ropivacaine hydrochloride	ropivacaine hydrochloride	Fresenius Kabi Usa	020533	28 Nov 2026	patent

Drug	Ingredient	Applicant	NDA	Earliest generic entry	Basis
Clindesse clindamycin phosphate	clindamycin phosphate	Padagis Us	050793	2 Dec 2026	patent
Protonix pantoprazole sodium	pantoprazole sodium	Wyeth Pharms	022020	7 Dec 2026	patent
Signifor · 3 strengths pasireotide diaspartate	pasireotide diaspartate	Recordati Rare	200677	14 Dec 2026	patent
Tissueblue brilliant blue g	brilliant blue g	Dutch Ophthalmic	209569	20 Dec 2026	exclusivity